TrialAnnals of surgical oncology2016

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.

Robert H I Andtbacka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.